India's drug pricing authority may soon approve a price hike for vital platinum-based cancer medicines. These drugs, including carboplatin ...

The National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices for 30 essential drug formulations, including those for diabet...

Senior IAS officer Kamlesh Kumar Pant has been given the additional charge of Chief Secretary in Himachal Pradesh. He currently holds posit...

Government health spending has risen, leading to a significant drop in out-of-pocket health expenses. This decline, from 64.2% in 2013-14 t...

A Gujarat NGO is pushing the government to regulate nutraceuticals like medicines. They cite concerns about product quality and unregulated...

The ongoing conflict in Iran is impacting India's healthcare sector. Pharmaceutical distributors warn of significant price increases for es...

FOPE said that the manufactures follow the rules as laid down in the DPCO, 2013. At the same time, manufacturers look to NPPA to fix the pr...

ET Online retraces here the tenures of NPPA chiefs. The question to ask: Is taking on the pharma and healthcare lobby injurious to the NPPA...

NPPA's study found that "the major beneficiaries of profits in all these cases because of inflated MRPs have been hospitals rather than dru...

The National Pharmaceutical Pricing Authority (NPPA) has also revised the prices of three formulations, including that of anti cancer drug ...

In a written reply to a question in the Rajya Sabha, Minister of State for Chemicals and Fertilisers Mansukh L Mandaviya said the governmen...

NPPA presently functions as an autonomous body that regulates prices of medicines under National List of Essential Medicines and monitors p...

In case of non-compliance of NPPA's instructions, the regulator said it may be constrained to invoke provisions of legal prosecution under ...

NPPA, on its part, has asserted that it would stand its ground should the issue go to court as its notification is correct as per law and u...

NPPA is trying to recover a whopping Rs 4,551 crore, including interest, from various pharma companies for overcharging as of February this...

Prices of around 12,000 stock keeping units (SKUs) of medicines have come down during January this year as a consequence of implementation ...

The DoP has asked NPPA to revisit the decision of fixing ceiling prices of various insulin formulations in the wake of review applications ...